Retroviruses and AIDS (Autism Immune Deficiency Syndrome):

ASD: An Acquired Immune Deficiency:

One In Two: New strategies for prevention and treatment:


If one considers autism spectrum disorders (ASD) as an acquired immune deficiency in which exposure to biotoxins including chemicals, heavy metals, GMO foods, and excessive vaccinations in susceptible populations contributes to progression and severity of disease development, significant opportunities exist to prevent and reverse the disease process! In this presentation, Dr. Mikovits will discuss simple ways to avoid biotoxin exposure and knowledge gained from more than three decades of treatment and drug development successfully implemented in HIV/AIDS. Dr. Mikovits will also discuss specific cases of significant improvement in people with ASD for more than two decades using this treatment strategy!

   (Scroll down to see Slides)


This presentation will cover how an autism dad found himself co-writing a book with retroviral and cancer researcher, Dr. Judy Mikovits. This collaboration, "PLAGUE - One Scientist's Intrepid Search for the Truth About Human Retroviruses and Chronic Fatigue Syndrome (ME/CFS), Autism and Other Diseases" gives an unparalleled glimpse into the corruption of high-profile science in our country and the impact this has on different disease communities including autism, ME/CFS, and cancer.


Kent Heckenlively, JD, is a science teacher, attorney, and coauthor of "PLAGUE - One Scientist's Intrepid Search for the Truth About Human Retroviruses and Chronic Fatigue Syndrome (ME/CFS), Autism and Other Diseases."

Kent Heckenlively and Judy Mikovits, PhD - Autism One 2015  Presentations

Judy Mikovits, PhD

   PLAGUE

Stain of Xenograft Human/Mouse Cells

Retroviruses and AIDS (Autism Immune Deficiency Syndrome) - Kent Heckenlively   

Increasing evidence highlights a role for immune dysfunction in the pathogenesis of autism spectrum disorder (ASD), as immune dysregulation is observed in the brain, periphery, and gastrointestinal tract of ASD individuals and their families. Moreover, a large number of patients have a clear family history of inflammatory disease and/or onset, relapsing, and progressive disease resulting from ongoing or repeated biotoxin exposure including chemicals, heavy metals, GMO foods, and vaccines.


Cross-talk between biotoxins and microorganisms leads to the development of neuroimmune disease in patient populations with known deficits in detoxification, methylation, and immune response to pathogens. Exposure to biotoxins must be minimized in order to prevent disease development. Conceptualizing the illness as an acquired immune deficiency suggests strategies for management and prevention.

Kent Heckenlively